InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by GAROFALO ELIZABETH A., Director. Director active across 2 companies, notably Acadia Pharmaceuticals INC. Cumulatively, 3 disclosures have been recorded. The latest transaction was disclosed on 16 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
09,459 shares0
Common Stock
SEC:0001209191-22-038536:0·
1,918 shares
Common Stock
SEC:0001209191-21-058556·
1,918 shares
Common Stock
SEC:0001209191-21-058556:0·
3 of 3 declarations
About GAROFALO ELIZABETH A.
Elizabeth A. Garofalo is a Director at Acadia Pharmaceuticals Inc. and Alector, Inc. She brings her expertise and experience to the board, contributing to the strategy and governance of these companies. Her role is crucial for ensuring the growth and sustainability of Acadia Pharmaceuticals Inc. and Alector, Inc.
